{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T22:09:01Z","timestamp":1782943741648,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA013429"],"award-info":[{"award-number":["DA013429"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-15-1-0252"],"award-info":[{"award-number":["W81XWH-15-1-0252"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.lfs.2021.120014","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T12:48:12Z","timestamp":1633438092000},"page":"120014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Chemokine receptor antagonists enhance morphine's antinociceptive effect but not respiratory depression"],"prefix":"10.1016","volume":"285","author":[{"given":"Saadet","family":"Inan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Eisenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Meissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen B.","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Tallarida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menahem","family":"Doura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Rawls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin W.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby K.","family":"Eisenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.120014_bb0005","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2016 National Survey on Drug Use and Health (NSDUH)","author":"Ahrnsbrak","year":"2017"},{"key":"10.1016\/j.lfs.2021.120014_bb0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ejp.1328","article-title":"Why \u03bc-opioid agonists have less analgesic efficacy in neuropathic pain?","volume":"23","author":"Martinez-Navarro","year":"2019","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.lfs.2021.120014_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-3959(88)90198-4","article-title":"Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain","volume":"33","author":"Arner","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2021.120014_bb0020","doi-asserted-by":"crossref","first-page":"10276","DOI":"10.1073\/pnas.102327699","article-title":"Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain","volume":"99","author":"Szabo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120014_bb0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.brainres.2007.03.066","article-title":"The chemokine CX3CL1\/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periacqueductal grey area of rats","volume":"1153","author":"Chen","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2021.120014_bb0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drugalcdep.2006.09.010","article-title":"Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats","volume":"88","author":"Chen","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.lfs.2021.120014_bb0035","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bbi.2011.04.014","article-title":"The effect of gp120 on morphine's antinociceptive and neurophysiological actions","volume":"25","author":"Chen","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.lfs.2021.120014_bb0040","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4049\/jimmunol.173.1.594","article-title":"Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize \u03bc-opioid receptors on dorsal root ganglia neurons","volume":"173","author":"Zhang","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2021.120014_bb0045","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.188.2.317","article-title":"Opiates trans-deactivate chemokine receptors: \u03b4 and \u03bc opiate receptor-mediated heterologous desensitization","volume":"188","author":"Grimm","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2021.120014_bb0050","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bbi.2010.10.020","article-title":"Interactions between chemokine and mu-opioid receptors: anatomical findings and electrophysiological studies in the rat periacqueductal gray","volume":"25","author":"Heinisch","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.lfs.2021.120014_bb0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejphar.2003.10.033","article-title":"Heterodimerization and cross-desensitization between the \u03bc-opioid receptor and the chemokine CCR5 receptor","volume":"483","author":"Chen","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120014_bb0060","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/excr.2002.5638","article-title":"Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells","volume":"280","author":"Suzuki","year":"2002","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.lfs.2021.120014_bb0065","doi-asserted-by":"crossref","first-page":"20354","DOI":"10.1074\/jbc.M110.177303","article-title":"Protein kinase C\u03b6 mediates \u03bc-opioid receptor-induced cross-desensitization of chemokine receptor CCR5","volume":"286","author":"Song","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120014_bb0070","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1124\/jpet.118.252890","article-title":"Coadministration of chemokine receptor antagonists with morphine potentiates morphine's analgesic effect on incisional pain in rats","volume":"367","author":"Inan","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2021.120014_bb0075","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/j.bja.2019.01.021","article-title":"Chemokine receptor antagonists enhance the antinociceptive activity of oxycodone and meperidine on incisional pain in rats","volume":"122","author":"Inan","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.lfs.2021.120014_bb0080","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbi.2013.11.010","article-title":"Src family kinases involved in CXCL12-induced loss of acute morphine analgesia","volume":"38","author":"Rivat","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"3 Suppl.","key":"10.1016\/j.lfs.2021.120014_bb0085","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.lfs.2021.120014_bb0090","doi-asserted-by":"crossref","first-page":"25562","DOI":"10.1074\/jbc.M000692200","article-title":"Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists","volume":"275","author":"Mirzadegan","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120014_bb0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9440(10)63292-0","article-title":"Blockade of CCR2 ameliorates progressive fibrosis in kidney","volume":"165","author":"Kitagawa","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2021.120014_bb0100","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1021\/jm3012273","article-title":"Substituted 7-amino-5-thio-thiazole[4,5-d]pyrimidines as potent and selective antagonists of the fractalkine receptor (CX3CR1)","volume":"56","author":"Karlstrom","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2021.120014_bb0105","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/BJ20150520","article-title":"AZD8797 is an allosteric non-competitive modulator of the human CX3CR1 receptor","volume":"473","author":"Cederblad","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.lfs.2021.120014_bb0110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0022-3565(25)22071-7","article-title":"Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat","volume":"246","author":"Tiseo","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2021.120014_bb0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-0270(85)90116-5","article-title":"Formalin test in mice, a useful technique for evaluating mild analgesics","volume":"14","author":"Hunskaar","year":"1985","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.lfs.2021.120014_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0304-3959(87)90088-1","article-title":"The formalin test in mice: dissociation between inflammatory and non-inflammatory pain","volume":"30","author":"Hunskaar","year":"1987","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2021.120014_bb0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pbb.2004.12.002","article-title":"A preclinical comparison between different opioids: antinociceptive versus adverse effects","volume":"80","author":"Meert","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.lfs.2021.120014_bb0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.vascn.2015.11.001","article-title":"Robustness of arterial blood gas analysis for assessment of respiratory safety pharmacology in rats","volume":"78","author":"Whiteside","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.lfs.2021.120014_bb0135","series-title":"Applied Mixed Models in Medicine","author":"Brown","year":"1999"},{"key":"10.1016\/j.lfs.2021.120014_bb0140","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2016.048","article-title":"Analysis of longitudinal data from animals with missing values using SPSS","volume":"11","author":"Duricki","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.lfs.2021.120014_bb0145","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1471-244X-13-240","article-title":"Efficacy and safety of haloperidol versus atypical antipsychotic meedication in the treatment of delerium","volume":"13","author":"Yoon","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.lfs.2021.120014_bb0150","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0091-3057(87)90351-0","article-title":"Sex and day-night differences in opiate-induced responses of insular wild deer mice, peromyscus maniculatus triangularis","volume":"27","author":"Kavaliers","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.lfs.2021.120014_bb0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.yhbeh.2007.09.003","article-title":"Sex chromosome complement affects nociception in tests of acute and chronic exposure to morphine in mice","volume":"53","author":"Gioiosa","year":"2008","journal-title":"Horm. Behav."},{"key":"10.1016\/j.lfs.2021.120014_bb0160","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/j.pain.0000000000001420","article-title":"Increased pain sensitivity and decreased opioid analgesia in T-cell-deficient mice and implications for sex differences","volume":"160","author":"Rosen","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2021.120014_bb0165","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1073\/pnas.1331358100","article-title":"Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2","volume":"100","author":"Abbadie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120014_bb0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.brainresrev.2008.12.002","article-title":"Chemokines and pain mechanisms","volume":"60","author":"Abbadie","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.lfs.2021.120014_bb0175","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1523\/JNEUROSCI.21-14-05027.2001","article-title":"Chemokines and glycoprotein 120 produce pain hypersensitivity by directly exciting primary nociceptive neurons","volume":"21","author":"Oh","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2021.120014_bb0180","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1471-4159.2008.05429.x","article-title":"Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated mice","volume":"106","author":"Dansereau","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2021.120014_bb0185","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1111\/j.1460-9568.2004.03709.x","article-title":"Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats","volume":"20","author":"Milligan","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.lfs.2021.120014_bb0190","first-page":"3418","article-title":"Pharmacological blockage of CXCR3 by (+)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness-evidence from in vivo and in vitro studies","volume":"2018","author":"Piotrowska","year":"1864","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.lfs.2021.120014_bb0195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2012.10.030","article-title":"Decreased pain responses of C-C chemokine receptor 5 knockout mice to chemical or inflammatory stimuli","volume":"67","author":"Lee","year":"2013","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.lfs.2021.120014_bb0200","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.eururo.2016.02.058","article-title":"The expression of inflammatory mediators in bladder pain syndrome","volume":"70","author":"Offiah","year":"2016","journal-title":"Eur. J. Urol."},{"key":"10.1016\/j.lfs.2021.120014_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2013.10.004","article-title":"Chemokines as peripheral pain mediators","volume":"557","author":"Dawes","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2021.120014_bb0210","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.pharep.2018.01.006","article-title":"The importance of chemokines in neuropathic pain development and opioid analgesic potency","volume":"70","author":"Kwiatkowski","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.lfs.2021.120014_bb0215","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1073\/pnas.0406030102","article-title":"A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120014_bb0220","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1476-5381.1991.tb12502.x","article-title":"Interleukin-8 as a mediator of sympathetic pain","volume":"104","author":"Cunha","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120014_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002193","article-title":"CXCL5 mediates UVB irradiation-induced pain","volume":"3","author":"Dawes","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2021.120014_bb0230","doi-asserted-by":"crossref","first-page":"14092","DOI":"10.1073\/pnas.0503496102","article-title":"Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neuron after chronic compression of the dorsal root ganglion","volume":"102","author":"White","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120014_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1744806916636385","article-title":"Crosstalk between astrocytic CXCL12 and microglial CXCR4 contributes to the development of neuropathic pain","volume":"12","author":"Luo","year":"2016","journal-title":"Mol. Pain"},{"key":"10.1016\/j.lfs.2021.120014_bb0240","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s11064-016-1943-8","article-title":"Early repeated administration of CXCR4 antagonist AMD3100 dose-dependently improves neuropathic pain in rats after L5 spinal nerve ligation","volume":"41","author":"Xie","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2021.120014_bb0245","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/gt.2013.90","article-title":"HSV-meidated p55TNFSR reduces neuropathic pain induced by HIV gp120 in rats through CXCR4 activity","volume":"21","author":"Huang","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.lfs.2021.120014_bb0250","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1744-8069-10-42","article-title":"CXCR4 chemokine receptor signaling mediates pain in diabetic neuropathy","volume":"10","author":"Menichella","year":"2014","journal-title":"Mol. Pain"},{"key":"10.1016\/j.lfs.2021.120014_bb0255","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pain.2011.09.022","article-title":"Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103, which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation","volume":"153","author":"Padi","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2021.120014_bb0260","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1523\/JNEUROSCI.1850-04.2004","article-title":"A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine","volume":"24","author":"Johnston","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2021.120014_bb0265","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/AJP.0000000000000319","article-title":"Involvement of CCL3\/CCR5 signalling in dorsal root ganglion inremifentanyl-induced hyperalgesia in rats","volume":"32","author":"Li","year":"2016","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.lfs.2021.120014_bb0270","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11481-017-9729-6","article-title":"The RS504393 influences the level of nociceptive factors and enhances opioid analgesic potency in neuropathic rats","volume":"12","author":"Kwiatkowski","year":"2017","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.lfs.2021.120014_bb0275","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cyto.2019.03.007","article-title":"Chemokines CCL2 and CCL7, but not CCL12, playa significant role in the development of pain-related behavior and opioid-induced analgesia","volume":"119","author":"Kwiatkowski","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.lfs.2021.120014_bb0280","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12031-013-0223-1","article-title":"Activation of CXCL10\/CXCR3 signaling attenates morphine analgesia: involvement of gi protein","volume":"53","author":"Ye","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2021.120014_bb0285","doi-asserted-by":"crossref","first-page":"8647","DOI":"10.1021\/acs.jmedchem.5b01245","article-title":"Inhibition of inflammatory and neuropathic pain by targeting a mu opioid receptor\/chemokine receptor 5 heteromer (MOR-CCR5)","volume":"58","author":"Akg\u00fcn","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2021.120014_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.04.004","article-title":"The bivalent ligand MCC22 potently attenuates hyperalgesia in a mouse model of cisplatin-evoked neuropathic pain without tolerance or reward","volume":"158","author":"Cataldo","year":"2019","journal-title":"Neuropharmacology"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521010018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521010018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:40:40Z","timestamp":1770399640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521010018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":58,"alternative-id":["S0024320521010018"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120014","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemokine receptor antagonists enhance morphine's antinociceptive effect but not respiratory depression","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120014"}}